Reagent Kit for Quantitative Determination of Pregnancy-Associated Plasma Protein A (PAPP-A) in Human Serum Using Lanthanide Immunofluorescent Assay "PAPP-A-LIFA" According to TU 9398-035-18619450-2007

Reagent Kit for Quantitative Determination of Pregnancy-Associated Plasma Protein A (PAPP-A) in Human Serum Using Lanthanide Immunofluorescent Assay "PAPP-A-LIFA" According to TU 9398-035-18619450-2007

"PAPP-A-LIFA" Reagent Kit

The "PAPP-A-LIFA" reagent kit is intended for the quantitative determination of pregnancy-associated plasma protein A (PAPP-A) in human serum and plasma. The analysis is carried out using the lanthanide immunofluorescent assay method.

The product complies with the standards of TU 9398-035-18619450-2007 and includes the following components:

• 96-well polystyrene strip plate with mouse monoclonal anti-PAPP-A antibodies absorbed onto the inner surface of the wells.
• Calibrators based on bovine embryonic serum, containing known quantities of PAPP-A.
• Control serum based on human serum with a known PAPP-A concentration.
• Concentrated conjugate.
• Enhancement buffer.
• LIFA buffer.
• Concentrated wash solution.

© 2024 All rights reserved. Our Company.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Quantitative Determination of Pregnancy-Associated Plasma Protein A (PAPP-A) in Human Serum Using Lanthanide Immunofluorescent Assay "PAPP-A-LIFA" According to TU 9398-035-18619450-2007, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.